| J9271 | Injection, pembrolizumab, 1 mg | 12,800 | $40 | $550.4K |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 8,190 | $40 | $294.9K |
| J0897 | Injection, denosumab, 1 mg | 14,040 | $20 | $252.7K |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 4,750 | $30 | $123.6K |
| J1437 | Injection, ferric derisomaltose, 10 mg | 6,700 | $20 | $107.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,400 | $70 | $91.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 550 | $100 | $53.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 490 | $90 | $46.4K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 6,140 | $10 | $36.8K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 230 | $120 | $27.7K |